EyePoint Pharmaceuticals ...

NASDAQ: EYPT · Real-Time Price · USD
8.94
0.69 (8.36%)
At close: Jun 06, 2025, 3:59 PM
8.60
-3.75%
After-hours: Jun 06, 2025, 04:49 PM EDT
8.36%
Bid 6.4
Market Cap 614.83M
Revenue (ttm) 56.04M
Net Income (ttm) -146.78M
EPS (ttm) -2.42
PE Ratio (ttm) -3.69
Forward PE -2.82
Analyst Buy
Ask 10.7
Volume 828,812
Avg. Volume (20D) 831,603
Open 7.49
Previous Close 8.25
Day's Range 8.34 - 9.09
52-Week Range 3.91 - 13.99
Beta 1.64

About EYPT

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EYPT
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for EYPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
+18.12%
EyePoint shares are trading higher after the compa... Unlock content with Pro Subscription
4 months ago
+2.36%
EyePoint Pharmaceuticals shares are trading higher after the company announced six-month results for its Phase 2 VERONA trial and stated the trial met its primary endpoint.